Augmented inhibition of CYP3A4 in human primary hepatocytes by ritonavir solid drug nanoparticles

Philip Martin, Marco Giardiello, Tom McDonald, Darren Smith, Marco Siccardi, Steven Rannard, Andrew Owen

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	3556-3568
Journal	Molecular Pharmaceutics
Volume	12
Issue number	10
DOIs	https://doi.org/10.1021/acs.molpharmaceut.5b00204
Publication status	Published - 8 Sept 2015

Access to Document

@article{fcda38eb98cd4df88e89553443d3556a,

title = "Augmented inhibition of CYP3A4 in human primary hepatocytes by ritonavir solid drug nanoparticles",

author = "Philip Martin and Marco Giardiello and Tom McDonald and Darren Smith and Marco Siccardi and Steven Rannard and Andrew Owen",

note = "Published online first.",

year = "2015",

month = sep,

day = "8",

doi = "10.1021/acs.molpharmaceut.5b00204",

language = "English",

volume = "12",

pages = "3556--3568",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

number = "10",

}

TY - JOUR

T1 - Augmented inhibition of CYP3A4 in human primary hepatocytes by ritonavir solid drug nanoparticles

AU - Martin, Philip

AU - Giardiello, Marco

AU - McDonald, Tom

AU - Smith, Darren

AU - Siccardi, Marco

AU - Rannard, Steven

AU - Owen, Andrew

N1 - Published online first.

PY - 2015/9/8

Y1 - 2015/9/8

U2 - 10.1021/acs.molpharmaceut.5b00204

DO - 10.1021/acs.molpharmaceut.5b00204

M3 - Article

SN - 1543-8384

VL - 12

SP - 3556

EP - 3568

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

IS - 10

ER -